Chief Financial Officer
Simon Dingemans - download image (JPG)
Simon became Chief Financial Officer in April 2011 after joining as Chief Financial Officer Designate in January 2011. He is a member of the Board and the Corporate Executive Team.
Simon joined GSK from Goldman Sachs International where he was a Managing Director and Partner. He joined Goldman Sachs in 1995, becoming Head of UK Investment Banking and later becoming a leader of the European Mergers and Acquisitions business.
As part of his role at GSK, Simon is responsible for Global Finance and several of the company’s key global functions including Tech and Worldwide Real Estate & Facilities. He worked with GSK for over a decade prior to joining the company and was closely involved in a number of GSK’s most important strategic projects during that time, including the establishment of ViiV Healthcare. After receiving a Masters degree in Geography from Oxford University in 1985, Simon joined S.G. Warburg Group, the investment banking firm which specialised in mergers and acquisitions, becoming one of its youngest directors in 1994.
Simon is a Trustee of The Donmar Warehouse and previously Chairman of the 100 Group of Finance Directors between 2014 and 2016.
In May 2018, Simon informed the Board of his intention to retire from the company and to step down from the Board in May 2019. Iain Mackay joined GSK on 14 January 2019 as Chief Financial Officer Designate.
Find out more
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
Discover our latest financial performance announcement and search for historical quarterly results materials
Board of Directors
The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance.
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business